Pillstats
Rx only · Capsule · Oral

Aprepitant

Brands: Emend · Aprepitant

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US18 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)358255
US makers6 labelers
Packages28
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 21 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$60.08$120.17$180.25$240.33Jan 2025Mar 2026Jul 2026
$75.408
Latest avg · Jul 22, 2026
-64%
Since Jan 22, 2025
6
Active US suppliers
39%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.4K4.7K7.1K9.4K2025 Q12025 Q22025 Q32025 Q42026 Q1
6.3K
Rx · 2026 Q1
31K
Units dispensed
-12%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Glenmark Pharmaceuticals Inc., USAunknown6SUPPLYING
Sandoz Incunknown5SUPPLYING
Golden State Medical Supply, Inc.unknown5SUPPLYING
Torrent Pharmaceuticals Limitedunknown5SUPPLYING
BluePoint Laboratoriesunknown5SUPPLYING
Merck Sharp & Dohme LLC.unknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 8, 2026
    RESOLVEDShortage resolved: Aprepitant Oral Powder for Suspension (Merck Sharp & Dohme LLC)

    Aprepitant Oral Powder for Suspension — reported in shortage by Merck Sharp & Dohme LLC. Therapeutic category: Gastroenterology.

  • Apr 8, 2026
    SHORTAGEDrug shortage: Aprepitant Oral Powder for Suspension (Merck Sharp & Dohme LLC)

    Aprepitant Oral Powder for Suspension — reported in shortage by Merck Sharp & Dohme LLC. Therapeutic category: Gastroenterology.

  • Dec 12, 2025
    RECALLRecall (Class II): Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme …

    Presence of particulate matter: potential presence of metal particulates in the product. — Recalling firm: Merck Sharp & Dohme LLC — Nationwide in the USA

  • Apr 13, 2022
    RECALLRecall (Class II): Aprepitant Capsule, USP, 40 mg, 1 capsule per unit dose package, Rx only, MFG: Sandoz Pharma, NDC 0781-2321-06

    cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.

  • Nov 27, 2018
    RECALLRecall (Class III): Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceutic…

    Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide